Top of Page
Skip main navigation

Kempuraj Duraisamy, Ph.D.


Co-Director, E.M. Papper Laboratory of Clinical Immunology

Associate Professor, Institute for Neuro-Immune Medicine, Nova Southeastern University

 

Dr. Kempuraj Duraisamy has recently joined Nova Southeastern University as an Associate Professor at the Institute of Neuro-Immune Medicine, and Co-Director of the E.M. Papper Laboratory of Clinical Immunology at Nova Southeastern University. 

Dr. Duraisamy received his Bachelor of Science, Master of Science, Master of Philosophy, and Doctor of Philosophy from University of Madras in Chennai, India. He later was a Postdoctoral Fellow at National Children's Medical Research Center in Tokyo, Japan and at Tufts University School of Medicine in Boston, Massachusetts where he studied inflammation and immunology.

Dr. Duraisamy's research is focused on the long-term effects of neuroimmune and neurodegenerative disorders, traumatic brain injury (TBI), and stress comorbidity in Alzheimer’s disease (AD) pathogenesis and biomarkers for neuroimmune/inflammatory diseases. He has a broad background in neuroinflammation, biomarkers, brain cell culture, anti-inflammatory- natural molecules, and mast cells which spans over 20 years.

 

Return to Our Team

 

  • U54 center grant - Patient subgroups, novel biomarker signatures and In vitro neuroinflammation modeling using activation of human microglia in the pathogenesis and treatment of ME/CFS
  • MPIs: N Klimas & TC Theoharides; Key Personnel/Co-Core Lead: Kempuraj Duraisamy
  • Department of Defense (DoD) “Biomarkers of neuroinflammation, brain organoid disease surrogate and use of eriodyctiol in the pathogenesis and treatment of AD”
  • PI: Theoharides Co-I: Kempuraj Duraisamy
  • Submitted VA Merit grant application entitled “Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases”
  • PI: Rajiv R. Mohan; Key Personnel/Co-I: Kempuraj Duraisamy
  • Submitted VA Merit grant application entitled “Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal Diseases”
  • PI: Rajiv R. Mohan; Key Personnel/Co-I: Kempuraj Duraisamy.
2022
  • Corneal stromal repair and regeneration
  • Mohan RR, Kempuraj D, D'Souza S, Ghosh A. Prog Retin Eye Res. 2022 May 29:101090. doi: 10.1016/j.preteyeres.2022.101090. Epub ahead of print. PMID: 35649962.
 
2021
 
2020
  • Current Trends in Biomarkers for Traumatic Brain Injury
  • Mehta T, Fayyaz M, Giler GE, Kaur H, Raikwar SP, Kempuraj D, Selvakumar GP, Ahmed ME, Thangavel R, Zaheer S, Iyer S, Govindarajan R, Zaheer A. Open Access J Neurol Neurosurg. 2020;12(4):86-94. Epub 2020 Jan 8. PMID: 32775958; PMCID: PMC7410004.

 

Complete List of Dr. Duraisamy's published work.
Return to top of page